abrdn Global Income Fund, Inc. (NY:FCO)
Price and Volume
Detailed Quote| Volume | 172,930 |
| Open | 2.910 |
| Bid (Size) | 2.910 (13,400) |
| Ask (Size) | 2.920 (200) |
| Prev. Close | 2.940 |
| Today's Range | 2.910 - 3.000 |
| 52wk Range | 2.810 - 6.773 |
| Shares Outstanding | N/A |
| Dividend Yield | 28.87% |
Top News
More News
Performance
More News
Read More
abrdn Glb Inc Fund: Dividend Insights ↗
February 16, 2024
abrdn Glb Inc Fund: Dividend Insights ↗
January 18, 2024
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
February 11, 2025
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
January 10, 2025
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
December 10, 2024
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
November 11, 2024
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
December 11, 2023
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
October 11, 2023
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
September 12, 2023
Frequently Asked Questions
Is abrdn Global Income Fund, Inc. publicly traded?
Yes, abrdn Global Income Fund, Inc. is publicly traded.
What exchange does abrdn Global Income Fund, Inc. trade on?
abrdn Global Income Fund, Inc. trades on the New York Stock Exchange
What is the ticker symbol for abrdn Global Income Fund, Inc.?
The ticker symbol for abrdn Global Income Fund, Inc. is FCO on the New York Stock Exchange
What is the current price of abrdn Global Income Fund, Inc.?
The current price of abrdn Global Income Fund, Inc. is 2.910
When was abrdn Global Income Fund, Inc. last traded?
The last trade of abrdn Global Income Fund, Inc. was at 11/21/25 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.